Pemphigoid gestationis: current management

Lizbeth R A Intong; Dédée F Murrell

doi:10.1016/j.det.2011.06.013

Pemphigoid gestationis: current management

Dermatol Clin. 2011 Oct;29(4):621-8. doi: 10.1016/j.det.2011.06.013. Epub 2011 Aug 15.

Authors

Lizbeth R A Intong¹, Dédée F Murrell

Affiliation

¹ Department of Dermatology, James Laws House, St George Hospital, Gray Street, Kogarah, Sydney, NSW 2217, Australia.

PMID: 21925007
DOI: 10.1016/j.det.2011.06.013

Abstract

Pemphigoid gestationis is an autoimmune blistering disease of pregnancy caused by autoantibodies directed against BP180 (type XVII collagen) in the basement membrane zone. This article discusses the current management of this rare disease.

MeSH terms

Adrenal Cortex Hormones / therapeutic use
Anti-Bacterial Agents / therapeutic use
Antibodies, Monoclonal, Murine-Derived / therapeutic use
Azathioprine / therapeutic use
Cyclophosphamide / therapeutic use
Cyclosporine / therapeutic use
Dapsone / therapeutic use
Dermatologic Agents / therapeutic use*
Female
Goserelin / therapeutic use
Humans
Immunoglobulins, Intravenous / therapeutic use
Immunosuppressive Agents / therapeutic use
Niacinamide / therapeutic use
Pemphigoid Gestationis / drug therapy*
Pemphigoid Gestationis / therapy
Plasmapheresis
Pregnancy
Rituximab

Substances

Adrenal Cortex Hormones
Anti-Bacterial Agents
Antibodies, Monoclonal, Murine-Derived
Dermatologic Agents
Immunoglobulins, Intravenous
Immunosuppressive Agents
Goserelin
Niacinamide
Rituximab
Cyclosporine
Cyclophosphamide
Dapsone
Azathioprine